A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Clinical trial NCT04139304 · RECRUITING

Trial details

NCT number: NCT04139304
Sponsor: AIDS Malignancy Consortium
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Plasmablastic Lymphoma Ann Arbor Stage I Diffuse Large B-Cell Lymphoma Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma

Start date: 2021-05-24
Primary completion: 2029-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.